Skip to content

Comparison of the New Fitting Method Cochlear Nucleus Fitting Software (NFS) With the Established Fitting Method Cochlear Nucleus Custom SoundTM Suite (CSS)

Comparison of Fitting Methods Using Cochlear Clinical Care Innovation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02228148
Enrollment
48
Registered
2014-08-28
Start date
2014-11-30
Completion date
2017-12-15
Last updated
2018-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Loss

Keywords

Post linguistically deafness, severe to profound deafness

Brief summary

The purpose of this study is to evaluate if the new and simplified fitting method with Cochlear Nucleus Fitting Software (a major component of a suite of tools which form the Clinical Care Innovation) provides Cochlear Implants Recipients with the same hearing outcome as the current and established clinical fitting method with Cochlear Nucleus Custom SoundTM Suite. The Clinical Care Innovation method reduces fitting to simple volume, bass and trebles adjustments, operations which are familiar to anyone who has used an audio player.

Interventions

DEVICENFS

Cochlear Nucleus Fitting Software

DEVICECSS

Cochlear Nucleus Custom SoundTM Suite

Sponsors

numerics data GmbH
CollaboratorUNKNOWN
Cochlear
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Newly implanted subjects with available Nucleus Cochlear Implants compatible with CP900 series sound processors (excluding Cochlear Nucleus Hybrid) * Post linguistically deafened adults (≥ 18 years) * Unilaterally implanted * ≤ 15 years of severe to profound deafness prior to implantation * Subjects who are capable and willing to participate in speech perception tests in local language * Subjects who are able to provide feedback in form of a written questionnaire (e.g. Speech Spatial Hearing Qualities questionnaire) * Subjects willing to give their consent to the study

Exclusion criteria

* Additional handicaps that would prevent participation in evaluations (e.g. visual impairment, blindness) * Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the procedure/fitting method * Bilateral implantation * Hybrid-L (not supported by Nucleus Fitting Software) * Subjects who already have hearing experience with a Cochlear Implant (e.g. reimplantation, contralateral Cochlear Implant) * Subjects with single-sided deafness * Known cochlea malformations * Subjects who lost their hearing due to meningitis

Design outcomes

Primary

MeasureTime frameDescription
Speech perception performance in subjects fitted with Nucleus Fitting Software and subjects fitted with Nucleus Custom SoundTM Suite assessed via aided hearing thresholds3 months after implantationAdaptive Oldenburg Sentence Test in noise with speech at 65 dB (if the subject's understanding with Oldenburg Sentence Test in quiet is ≥ 70%).
Speech perception performance in subjects fitted with Nucleus Fitting Software and subjects fitted with Nucleus Custom SoundTM Suite assessed via speech performance tests3 months after implantationFreiburg Monosyllables and Oldenburg Sentence Test in quiet at 65 dB.

Secondary

MeasureTime frame
Hearing disability score in subjects fitted with Nucleus Fitting Software and subjects fitted with Nucleus Custom SoundTM Suite assessed via the Speech Spatial Hearing Qualities questionnaire (without spatial part)before first fitting post-implantation (1 day)
Subject preference for fittings performed with Nucleus Fitting Software and fittings with Nucleus Custom SoundTM Suite assessed via a subject comfort questionnaireafter each fitting (4 weeks after implantation)

Countries

Germany, Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026